These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2941403)

  • 1. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Blomquist IK; Kim KS
    J Antimicrob Chemother; 1986 May; 17(5):641-9. PubMed ID: 2941403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
    Infection; 1989; 17(1):31-4. PubMed ID: 2493429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
    Strunk RW; Gratz JC; Maserati R; Scheld WM
    Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
    Bayer AS; Lindsay P; Yih J; Hirano L; Lee D; Blomquist IK
    Antimicrob Agents Chemother; 1986 Oct; 30(4):528-31. PubMed ID: 3539007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.
    Gerber AU; Kozak S; Segessenmann C; Flückiger U; Bangerter T; Greter U
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):233-7. PubMed ID: 2496992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Norman D; Kim KS
    Antimicrob Agents Chemother; 1985 Dec; 28(6):781-5. PubMed ID: 3909954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
    Johnson PR; Liu Yin JA; Tooth JA
    J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
    Follath F; Bindschedler M; Wenk M; Frei R; Stalder H; Reber H
    Eur J Clin Microbiol; 1986 Apr; 5(2):236-40. PubMed ID: 2941289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
    Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
    Xiong YQ; Potel G; Caillon J; Stephant G; Jehl F; Bugnon D; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1995 Feb; 39(2):496-9. PubMed ID: 7726520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
    Schaad UB; Desgrandchamps D; Kraemer R
    Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M; Miniter P; Andriole VT
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
    Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
    Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX; Jules K; Neu HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.
    Reyes MP; Lerner AM
    Rev Infect Dis; 1983; 5(2):314-21. PubMed ID: 6405476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
    Hyatt DS; Rogers TR; McCarthy DM; Samson DS
    J Antimicrob Chemother; 1991 Aug; 28(2):324-6. PubMed ID: 1778867
    [No Abstract]   [Full Text] [Related]  

  • 19. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008.
    Reyes MP; Ali A; Mendes RE; Biedenbach DJ
    Medicine (Baltimore); 2009 Sep; 88(5):294-301. PubMed ID: 19745688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Hirano L; Yih J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.